DaVita DVA
$161.03 +$4.69 (+3.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $161.03 0.00%
Open$157.86
Prev close$156.34
Day range$157.20 – $162.99
Volume730.2K
Market cap$10.13B
P/E (TTM)11.9
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$3.58B+4.6% YoY
Operating profit$553.19M+11.6% YoY
Net profit$269.39M+12.1% YoY
Diluted EPS$3.40+66.7% YoY
Free cash flow$359.34M-46.8% YoY
Operating cash flow$518.83M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin32.3%
Operating margin15.2%
Net margin6.5%
Return on assets5.2%
Current ratio1.41
Liabilities / assets93.7%
Cash & investments$566.30M
Total debt$12.95B
Net cash (debt)-$12.39B
Free cash flow / sales9.1%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $3.58B | $3.55B | $3.42B | $13.64B | $3.62B |
| Total Operating Revenue | $3.58B | $3.55B | $3.42B | $13.64B | $3.62B |
| Cost of Revenue | $2.45B | $2.39B | $2.34B | $9.24B | $2.41B |
| Gross Profit | $1.13B | $1.16B | $1.07B | $4.40B | $1.21B |
| Operating Expense | $573.89M | $591.27M | $599.74M | $2.39B | $659.07M |
| Selling and Admin Expenses | $408.70M | $423.46M | $421.91M | $1.67B | $472.36M |
| -General & Admin Expense | $408.70M | $423.46M | $421.91M | $1.67B | $472.36M |
| Depreciation & Amortization & Depletion | $165.19M | $167.81M | $177.83M | $715.35M | $186.70M |
| -Depreciation & Amortization | $165.19M | $167.81M | $177.83M | $715.35M | $186.70M |
| Operating Profit | $553.19M | $570.82M | $473.55M | $2.01B | $551.21M |
| Net Non-Operating Interest Income (Expense) | -$150.02M | -$150.26M | -$145.13M | -$579.93M | -$148.25M |
| Non-Operating Interest Expense | $150.02M | $150.26M | $145.13M | $579.93M | $148.25M |
| Other Income (Expense) | -$44.47M | $14.45M | $12.82M | -$83.87M | -$20.19M |
| Earnings from Equity Interest | $8.24M | $8.18M | $8.34M | $33.00M | $9.87M |
| Special Income (Charges) | -$62.18M | -$2.04M | – | -$14.18M | -$9.03M |
| -Less:Impairment of Capital Assets | $62.18M | – | – | $0.00 | $0.00 |
| Other Non-Operating Income (Expenses) | $9.47M | $8.30M | $4.47M | -$102.69M | -$21.03M |
| Pretax Profit | $358.71M | $435.01M | $341.23M | $1.35B | $382.76M |
| Tax | $89.32M | $91.79M | $66.20M | $293.11M | $76.73M |
| Net Profit | $269.39M | $343.22M | $275.04M | $1.08B | $331.03M |
| Profit from Continuing Operations | $269.39M | $343.22M | $275.04M | $1.05B | $306.03M |
| Minority Interests | $46.46M | $77.83M | $77.51M | $331.91M | $96.81M |
| Net Income to Parent Company | $222.93M | $265.40M | $197.53M | $746.80M | $234.22M |
| Net Income to Common Stockholders | $222.93M | $265.40M | $197.53M | $746.80M | $234.22M |
| Basic EPS | $3.49 | $4.10 | $2.93 | $10.06 | $3.36 |
| Diluted EPS | $3.40 | $4.02 | $2.87 | $9.84 | $3.29 |
| -Less:Other Special Charges | – | $2.04M | – | $14.18M | $9.03M |
| -Less:Restructuring and Mergern & Acquisition | – | – | – | $0.00 | – |
| Net Income from Discontinuous Operations | – | – | – | $25.00M | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $17.82B | $17.71B | $17.50B | $17.48B | $17.48B |
| Total Current Assets | $4.07B | $4.19B | $4.06B | $4.06B | $4.06B |
| Cash and Cash Equivalents & Short-Term Investments | $566.30M | $688.88M | $666.55M | $700.74M | $700.74M |
| -Cash and Cash Equivalents | $495.63M | $668.96M | $644.24M | $676.44M | $676.44M |
| -Short Term Investments | $70.67M | $19.91M | $22.30M | $24.30M | $24.30M |
| Receivables | $3.12B | $3.12B | $3.01B | $2.96B | $2.96B |
| -Accounts Receivable | $2.51B | $2.47B | $2.46B | $2.41B | $2.41B |
| -Taxes Receivable | $47.81M | $84.60M | $35.78M | $49.94M | $49.94M |
| -Other Receivables | $565.46M | $565.57M | $517.65M | $494.41M | $494.41M |
| Inventory | $161.46M | $151.54M | $141.61M | $160.63M | $160.63M |
| Restricted Cash | $83.63M | $82.90M | $82.16M | $81.31M | $81.31M |
| Other Current Assets | $141.15M | $149.11M | $159.58M | $156.29M | $156.29M |
| Total Non-Current Assets | $13.74B | $13.52B | $13.44B | $13.42B | $13.42B |
| Net PPE | $5.17B | $5.18B | $5.15B | $5.21B | $5.21B |
| -Gross PPE | $12.15B | $12.05B | $11.90B | $11.81B | $11.81B |
| -Accumulated Depreciation | -$6.99B | -$6.87B | -$6.75B | -$6.60B | -$6.60B |
| Investments and Advances | $442.69M | $222.17M | $206.91M | $198.22M | $198.22M |
| -Available for Sale Securities | $38.38M | $38.37M | $34.96M | $36.55M | $36.55M |
| -Held to Maturity Securities | $0.00 | $0.00 | $4.51M | $4.42M | $4.42M |
| -Long Term Equity Investment | $404.31M | $183.80M | $167.44M | $157.25M | $157.25M |
| Goodwill and Other Intangible Assets | $7.77B | $7.82B | $7.81B | $7.77B | $7.77B |
| -Goodwill | $7.55B | $7.59B | $7.58B | $7.55B | $7.55B |
| -Other Intangible Assets | $221.07M | $228.82M | $229.02M | $222.13M | $222.13M |
| Other Non-Current Assets | $364.51M | $298.54M | $266.99M | $246.52M | $246.52M |
| Total Liabilities | $16.69B | $16.63B | $16.45B | $16.32B | $16.32B |
| Total Current Liabilities | $2.89B | $2.86B | $2.87B | $3.14B | $3.14B |
| Payables | $740.06M | $777.01M | $815.17M | $982.13M | $982.13M |
| -Accounts Payable | $662.20M | $715.87M | $691.26M | $696.15M | $696.15M |
| -Total Tax Payable | $23.14M | $24.62M | $37.42M | $86.04M | $86.04M |
| -Due to Related Parties Current | $54.71M | $36.51M | $86.50M | $199.94M | $199.94M |
| Short-Term Debt and Capital Lease Obligation | $550.62M | $556.67M | $544.87M | $534.69M | $534.69M |
| -Current Debt | $112.49M | $117.18M | $112.65M | $109.20M | $109.20M |
| -Current Capital Lease Obligation | $438.13M | $439.49M | $432.22M | $425.48M | $425.48M |
| Other Current Liabilities | $848.18M | $827.00M | $799.38M | $642.29M | $642.29M |
| Total Non-Current Liabilities | $13.80B | $13.77B | $13.58B | $13.18B | $13.18B |
| Long Term Debt and Capital Lease Obligation | $12.84B | $12.85B | $12.68B | $12.34B | $12.34B |
| -Long Term Debt | $10.66B | $10.66B | $10.51B | $10.16B | $10.16B |
| -Long Term Capital Lease Obligation | $2.19B | $2.19B | $2.16B | $2.18B | $2.18B |
| Non-Current Deferred Liabilities | $861.69M | $825.72M | $818.92M | $756.87M | $756.87M |
| Other Non-Current Liabilities | $100.43M | $99.09M | $88.85M | $83.52M | $83.52M |
| Total Equity | $1.13B | $1.08B | $1.05B | $1.16B | $1.16B |
| Stockholders' Equity | -$591.09M | -$765.10M | -$755.50M | -$651.08M | -$651.08M |
| Capital Stock | $69,000.00 | $69,000.00 | $69,000.00 | $69,000.00 | $69,000.00 |
| -Common Stock | $69,000.00 | $69,000.00 | $69,000.00 | $69,000.00 | $69,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $53.98M | $0.00 | $0.00 | $0.00 | $0.00 |
| Retained Earnings | $301.57M | $81.23M | -$179.24M | -$328.43M | -$328.43M |
| Less: Treasury Stock | -$917.24M | -$787.85M | -$489.36M | -$199.94M | -$199.94M |
| Gains/Losses Not Affecting Retained Earnings | -$29.46M | -$58.55M | -$86.96M | -$122.78M | -$122.78M |
| Minority Interests | $1.72B | $1.84B | $1.80B | $1.81B | $1.81B |
| Current Accrued Expenses | – | – | – | $189.05M | $189.05M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $518.83M | $490.07M | $320.83M | $1.89B | $540.73M |
| Net cash flow from continuing operations | $518.83M | $490.07M | $320.83M | $1.89B | $540.73M |
| Net Income from Continuing Operations | $269.39M | $343.22M | $275.04M | $1.08B | $331.03M |
| Gain/Loss from Continuing Operations | -$1.55M | $2.47M | -$30,000.00 | $146.70M | $50.91M |
| Depreciation & Depletion & Amortization | $165.19M | $167.81M | $177.83M | $715.35M | $186.70M |
| Deferred Tax | $37.78M | -$1.37M | $54.80M | $86.57M | $17.59M |
| Other Non-Cash Items | -$2.05M | $10.02M | $6.71M | -$17.55M | -$29.07M |
| Change in Working Capital | -$41.29M | -$58.11M | -$221.67M | -$263.24M | -$54.83M |
| -Change in Receivables | -$43.39M | $5.55M | -$29.75M | -$210.63M | -$65.94M |
| -Change in Inventory | -$10.21M | -$8.96M | $20.28M | -$19.95M | -$20.86M |
| -Change in Payables and Accrued Expense | $52.88M | $11.43M | -$112.12M | $128.30M | $30.42M |
| -Change in Other Current Assets | -$16.80M | -$55.80M | -$25.34M | -$164.55M | -$11.10M |
| -Change in Other Current Liabilities | $7.92M | $49.32M | -$101.86M | -$22.62M | -$24.91M |
| -Change In Other Working Capital | -$31.69M | -$59.66M | $27.13M | $26.20M | $37.56M |
| Net cash flow from investing | -$420.11M | -$194.25M | -$139.09M | -$654.95M | -$163.13M |
| Net Cash Flow from Continuing Investing Activities | -$420.11M | -$194.25M | -$139.09M | -$654.95M | -$163.13M |
| Net PPE Purchase and Sale | -$159.49M | -$169.82M | -$102.02M | -$575.86M | -$145.43M |
| Net Business Purchase and Sale | -$205.37M | -$21.93M | -$36.23M | -$144.50M | -$23.70M |
| Net Investment Purchase and Sale | -$67.38M | -$3.17M | -$4.67M | $29.70M | $4.14M |
| Net Other Investing Changes | $11.91M | $671,000.00 | $3.72M | $34.17M | $1.84M |
| Financing Cash Flow | -$271.13M | -$270.19M | -$213.34M | -$1.37B | -$414.52M |
| Net Cash Flow from Continuing Financing Activities | -$271.13M | -$270.19M | -$213.34M | -$1.37B | -$414.52M |
| Net Issuance Payments Of Debt | -$13.58M | $157.81M | $346.09M | $823.44M | $31.99M |
| Net Common Stock Issuance | -$109.52M | -$364.35M | -$396.31M | -$1.79B | -$328.83M |
| Proceeds from Stock Option Exercised | $8.60M | $3.52M | $2.39M | $23.29M | $5.71M |
| Net Other Financing Charges | -$156.63M | -$67.17M | -$165.51M | -$428.51M | -$123.39M |
| Ending Cash Balance | $579.26M | $751.86M | $726.40M | $757.75M | $757.75M |
| Net Change in Cash | -$172.41M | $25.63M | -$31.60M | -$143.23M | -$36.92M |
| Beginning Cash Balance | $751.86M | $726.40M | $757.75M | $879.83M | $795.41M |
| Effect of Exchange Rate Changes | -$189,000.00 | -$179,000.00 | $259,000.00 | $21.15M | -$746,000.00 |
| Free Cash Flow | $359.34M | $320.25M | $218.81M | $1.31B | $395.30M |
No comments yet — be the first to weigh in on DVA.
Sign in to join the discussion.